In vitro study of ticlopidine, as a model of antisickling action of platelet antiaggregant. 1984

M Sablayrolles, and H Wajcman, and J P Castaigne, and D Labie

The in vitro antisickling effect of ticlopidine may be explained by the action of the drug on the membrane. The drug molecule increases slightly the volume of the cell, decreases the mean intra-erythrocytic hemoglobin concentration and therefore affects the delay time for hemoglobin S polymerization.

UI MeSH Term Description Entries
D004910 Erythrocyte Membrane The semi-permeable outer structure of a red blood cell. It is known as a red cell 'ghost' after HEMOLYSIS. Erythrocyte Ghost,Red Cell Cytoskeleton,Red Cell Ghost,Erythrocyte Cytoskeleton,Cytoskeleton, Erythrocyte,Cytoskeleton, Red Cell,Erythrocyte Cytoskeletons,Erythrocyte Ghosts,Erythrocyte Membranes,Ghost, Erythrocyte,Ghost, Red Cell,Membrane, Erythrocyte,Red Cell Cytoskeletons,Red Cell Ghosts
D006451 Hemoglobin, Sickle An abnormal hemoglobin resulting from the substitution of valine for glutamic acid at position 6 of the beta chain of the globin moiety. The heterozygous state results in sickle cell trait, the homozygous in sickle cell anemia. Hemoglobin S,Deoxygenated Sickle Hemoglobin,Deoxyhemoglobin S,Hemoglobin SS,Hemoglobin, Deoxygenated Sickle,SS, Hemoglobin,Sickle Hemoglobin,Sickle Hemoglobin, Deoxygenated
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000925 Anticoagulants Agents that prevent BLOOD CLOTTING. Anticoagulant Agent,Anticoagulant Drug,Anticoagulant,Anticoagulant Agents,Anticoagulant Drugs,Anticoagulation Agents,Indirect Thrombin Inhibitors,Agent, Anticoagulant,Agents, Anticoagulant,Agents, Anticoagulation,Drug, Anticoagulant,Drugs, Anticoagulant,Inhibitors, Indirect Thrombin,Thrombin Inhibitors, Indirect
D000986 Antisickling Agents Agents used to prevent or reverse the pathological events leading to sickling of erythrocytes in sickle cell conditions. Desickling Agents,Agents, Antisickling,Agents, Desickling
D013876 Thiophenes A monocyclic heteroarene furan in which the oxygen atom is replaced by a sulfur. Thiophene
D013988 Ticlopidine An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES. 53-32C,Ticlid,Ticlodix,Ticlodone,Ticlopidine Hydrochloride,53 32C,5332C,Hydrochloride, Ticlopidine
D066298 In Vitro Techniques Methods to study reactions or processes taking place in an artificial environment outside the living organism. In Vitro Test,In Vitro Testing,In Vitro Tests,In Vitro as Topic,In Vitro,In Vitro Technique,In Vitro Testings,Technique, In Vitro,Techniques, In Vitro,Test, In Vitro,Testing, In Vitro,Testings, In Vitro,Tests, In Vitro,Vitro Testing, In

Related Publications

M Sablayrolles, and H Wajcman, and J P Castaigne, and D Labie
August 1984, Archivos de farmacologia y toxicologia,
M Sablayrolles, and H Wajcman, and J P Castaigne, and D Labie
March 2002, Vascular pharmacology,
M Sablayrolles, and H Wajcman, and J P Castaigne, and D Labie
October 1982, Il Farmaco; edizione pratica,
M Sablayrolles, and H Wajcman, and J P Castaigne, and D Labie
January 1988, Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi,
M Sablayrolles, and H Wajcman, and J P Castaigne, and D Labie
August 1987, Therapeutische Umschau. Revue therapeutique,
M Sablayrolles, and H Wajcman, and J P Castaigne, and D Labie
February 1986, Journal of pharmacobio-dynamics,
M Sablayrolles, and H Wajcman, and J P Castaigne, and D Labie
August 1992, Arquivos brasileiros de cardiologia,
M Sablayrolles, and H Wajcman, and J P Castaigne, and D Labie
June 2022, Scientific reports,
M Sablayrolles, and H Wajcman, and J P Castaigne, and D Labie
February 1992, Die Pharmazie,
M Sablayrolles, and H Wajcman, and J P Castaigne, and D Labie
June 1978, Thrombosis research,
Copied contents to your clipboard!